The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

rosepharma.com

Founded Year

2003

Stage

Series C | Alive

Total Raised

$10.85M

Last Raised

$6M | 15 yrs ago

About Rose Pharma

Rose Pharma is a developer of therapeutics for irritable bowel syndrome (IBS) and anorexia/cachexia associated with cancer and other major pathologies. The company's platform technology is based around glucagon-like peptide-1 (GLP-1), an endogenous peptide that has shown to stimulate insulin release from the pancreas while also reducing gastrointestinal motor activity. Its technology is designed to reduce contractions and muscular spasms associated with an IBS attack. [Keywords: hormone, insulin]

Rose Pharma Headquarters Location

Symbion Science Park Fruebjergvej 3

Copenhagen, 2100,

Denmark

45 353 87 997 0841

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Rose Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Rose Pharma is included in 2 Expert Collections, including Diabetes.

D

Diabetes

1,750 items

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Rose Pharma Patents

Rose Pharma has filed 2 patents.

The 3 most popular patent topics include:

  • Diabetes
  • G protein coupled receptors
  • Peptide hormones
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/2/2020

7/13/2021

G protein coupled receptors, Peptide hormones, Diabetes, Peptides, Proteins

Grant

Application Date

12/2/2020

Grant Date

7/13/2021

Title

Related Topics

G protein coupled receptors, Peptide hormones, Diabetes, Peptides, Proteins

Status

Grant

  • When was Rose Pharma founded?

    Rose Pharma was founded in 2003.

  • Where is Rose Pharma's headquarters?

    Rose Pharma's headquarters is located at Symbion Science Park, Copenhagen.

  • What is Rose Pharma's latest funding round?

    Rose Pharma's latest funding round is Series C.

  • How much did Rose Pharma raise?

    Rose Pharma raised a total of $10.85M.

  • Who are the investors of Rose Pharma?

    Investors of Rose Pharma include NB Capital, 123 Investment Managers, Capnova, Eli Lilly and Company, BioScience Managers and 5 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.